全文获取类型
收费全文 | 939篇 |
免费 | 55篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 24篇 |
妇产科学 | 24篇 |
基础医学 | 76篇 |
口腔科学 | 32篇 |
临床医学 | 137篇 |
内科学 | 232篇 |
皮肤病学 | 83篇 |
神经病学 | 16篇 |
特种医学 | 3篇 |
外科学 | 172篇 |
综合类 | 30篇 |
一般理论 | 1篇 |
预防医学 | 46篇 |
眼科学 | 8篇 |
药学 | 68篇 |
中国医学 | 23篇 |
肿瘤学 | 15篇 |
出版年
2021年 | 4篇 |
2020年 | 2篇 |
2019年 | 6篇 |
2018年 | 7篇 |
2017年 | 16篇 |
2016年 | 14篇 |
2015年 | 30篇 |
2014年 | 45篇 |
2013年 | 48篇 |
2012年 | 32篇 |
2011年 | 23篇 |
2010年 | 101篇 |
2009年 | 123篇 |
2008年 | 43篇 |
2007年 | 34篇 |
2006年 | 58篇 |
2005年 | 22篇 |
2004年 | 5篇 |
2003年 | 13篇 |
2002年 | 7篇 |
2001年 | 3篇 |
2000年 | 3篇 |
1999年 | 9篇 |
1998年 | 23篇 |
1997年 | 46篇 |
1996年 | 41篇 |
1995年 | 28篇 |
1994年 | 19篇 |
1993年 | 19篇 |
1992年 | 15篇 |
1991年 | 16篇 |
1990年 | 11篇 |
1989年 | 10篇 |
1988年 | 6篇 |
1987年 | 13篇 |
1986年 | 8篇 |
1985年 | 2篇 |
1984年 | 10篇 |
1983年 | 7篇 |
1981年 | 4篇 |
1980年 | 2篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1975年 | 2篇 |
1959年 | 9篇 |
1958年 | 17篇 |
1957年 | 9篇 |
1956年 | 9篇 |
1955年 | 2篇 |
1954年 | 9篇 |
排序方式: 共有997条查询结果,搜索用时 31 毫秒
1.
2.
Percutaneous Retrieval of Dislodged Left Atrial Appendage Occlusion Devices through the Transseptal Approach 下载免费PDF全文
SANG YEUB LEE M.D. JIN‐SEOK KIM M.D. SEUNG YONG SHIN M.D. HONG EUY LIM M.D. Ph.D. 《Pacing and clinical electrophysiology : PACE》2016,39(8):903-906
Percutaneous left atrial appendage (LAA) occlusion is a promising treatment option in patients with atrial fibrillation who have a high risk of embolic stroke and are not eligible for chronic oral anticoagulation therapy. This procedure, however, can induce several complications. Device embolization can result in a serious situation, requiring immediate and safe device removal. We report two cases in which dislodged LAA occlusion devices were flitting in the left atrium or entrapped in the mitral valve leaflets and were successfully retrieved through a transseptal approach without complications. 相似文献
3.
NEIL SULKE KIM TAN KAYVAN KAMALVAND JULIAN BOSTOCK CLIFF BUCKNALL 《Pacing and clinical electrophysiology : PACE》1996,19(11):1560-1567
Dual sensor ventricular demand rate responsive (VVIR mode) pacing was compared with single sensor rate responsive pacing to assess whether this new development should be more widely incorporated in modern pacemaker devices. A within patient randomized, double-blind crossover study involving ten patients, mean age 67.4 years (70% male), had Medtronic Legend Plus dual sensor VVIR pacemakers implanted for high grade A V block and chronic or persistent paroxysmal atrial fibrillation. Performance values were compared to 20 healthy control subjects of a similar age and gender. Patients were both subjectively and objectively assessed after 2 weeks of out-of-hospital activity in VVIR mode (minute ventilation sensing), VVIR mode (activity sensing), VVIR mode (dual sensor), and VVI mode (no rate response). All patients were assessed for subjective preference for, and objective improvement in, any pacing modality as assessed by standardized daily activity protocols and graded exercise treadmill testing. Subjective perception of exercise capacity and functional status was significantly lower in VVI mode (P < 0.05) compared to any of the VVIR modes, which did not differ. After completion of the study 70% of patients chose VVIR as their preferred mode, with 30% expressing no preference. Forty percent preferred activity sensor WIR mode pacing, 30% preferred dual sensor VVIR mode pacing, and 70% found either dual sensor WIR mode, minute ventilation sensor WIR mode, or both modalities least acceptable. No patient found activity sensing WIR mode least acceptable. Graded treadmill testing revealed significantly lower exercise tolerance during WI mode pacing (P < 0.01) compared to the VVIR modalities, which did not differ. Overall, chronotropic response was best with dual sensor pacing during standardized daily activity protocols and during the standard car journey. The data from this study suggest that there is no marked clinical advantage obtained from the use of dual sensor devices over current activity sensing ventricular demand rate responsive pacemakers, but with the probable added disadvantages of increased size, complexity, cost, and decreased longevity. 相似文献
4.
Myung-Hoon SHIN Jin-Sung KIM Kyeong-Sik RYU Jung-Woo HUR 《Neurologia medico-chirurgica》2015,55(7):570-577
The purpose of this study was to determine the feasibility and efficacy of bilateral decompression procedure via microscopic tubular crossing laminotomy (MTCL) for treating lumbar spinal stenosis (LSS). Seventeen patients with LSS underwent bilateral decompression via an MTCL procedure in which tubular retractor was placed. The mean age was 72 (range 59–84) years and there were 10 men and 7 women. All patients underwent pre- and postoperative dynamic lumbar x-ray, magnetic resonance (MR) image, and computed tomography. To verify the efficacy of this technique, pre- and postoperative cross-sectional area (CSA) of thecal sac, facet resection, and fatty infiltration (FI) of multifidus were measured. Clinical results were evaluated using Oswestry Disability Index (ODI), back and leg visual analog scale (VAS). The mean follow-up period was 17.5 months (range 12.1–21.2). 70.5% of MTCL was performed at the level of L4–5 and one case of dural violation (5.8%) was noted at the level of L5–S1. The mean preoperative CSA was 70.5 mm2 (range 25.1–87.6) and it increased to 198.8 mm2 (range 177.3–219.2) postoperatively (p = 0.00). The mean facet resection rate was 18.4% (range 9.9–26.9) and no radiological instability was noted postoperatively. MR image showed no increase in FI of the multifidus after 12 months of follow-up (p = 0.53). Preoperative clinical symptoms improved significantly at postoperative 6 months and 12 months of follow-up. These results indicate that an MTCL with use of tubular retractor system can be an effective procedure to achieve neural decompression for the treatment of LSS and it may be beneficial in preserving both facet joint and multifidus muscle. 相似文献
5.
6.
7.
8.
Seung Whan DOO Jae Heon KIM Won Jae YANG Yun Seob SONG 《Lower urinary tract symptoms.》2013,5(3):134-139
Objectives: The aim of the present study was to determine whether administration of zolpidem, a nonbenzodiazepine sedative‐hypnotic agent, at night would improve the nocturia unresponsive to alpha‐blocker monotherapy in men with lower urinary tract symptoms (LUTS). Methods: This was a prospective observational study comprised of 39 men aged 50 years and older. The study inclusion criteria were age more than 50 years, and nocturia twice or more per night after taking alpha‐blockers for more than 8 weeks. A total of 39 patients met the criteria and constituted the study cohort. Pittsburgh Sleep Quality Index (PSQI), International Prostate Symptom Score (IPSS), frequency volume chart (FVCs) and uroflowmetry were recorded. Patients were given 10 mg alfuzosin and 10 mg zolpidem once at night for the 8 weeks. Results: There were no serious side‐effects in any patient. Nocturia decreased from a baseline (3.1 ± 0.1) to 8 weeks (1.6 ± 0.2) (P = 0.001). After treatment, global PSQI scores and severe sleep disorders improved. Storage and voiding symptoms including total IPSS scores and quality of life index improved. Nocturnal urine volume and functional bladder capacity improved. Maximum flow rate, voided volume increased and residual urine volume decreased. Conclusion: Combined zolpidem and alpha‐blocker therapy resulted in a subjective and objective reduction in nocturia episodes when given to men with nocturia unresponsive to alpha‐blocker monotherapy. 相似文献
9.
H. S. LEE S. JEONG K. KIM J. H. KIM S. K. LEE B. H. KANG 《Xenobiotica; the fate of foreign compounds in biological systems》2013,43(5):423-429
1. The in vitro metabolism of the new insecticide flupyrazofos was studied using rat liver microsomes. Two metabolites were produced and identified as O, O -diethyl O -(1- phenyl-3-trifluoromethyl-5-pyrazoyl) phosphoric acid ester (flupyrazofos oxon) and 1- phenyl-3-trifluoromethyl-5-hydroxypyrazole (PTMHP) based on UV and mass spectral analysis. 2. Cytochrome P450 oxidatively converted flupyrazofos to flupyrazofos oxon, a major metabolite and phenobarbital-induced microsomes increased this desulphuration by 8- fold. 3. Flupyrazofos oxon was converted to PTMHP with a half-life of 47 8?min by chemical hydrolysis and this conversion also proceeded non-enzymatically under our microsomal incubation conditions. 相似文献
10.
Haejung LEE Myoung‐Soo KIM Kyung‐Yeon PARK Hyoung‐Sook PARK In‐Joo KIM 《Japan Journal of Nursing Science》2011,8(2):129-139
Aim: This study aimed to evaluate the immediate and long‐term effects of a 12 week problem‐solving (PS) counseling program to facilitate intensified walking with machinery monitoring on persons with type 2 diabetes mellitus in Korea. Methods: The study used a quasi‐experimental design. The participants were 57 patients with diabetes from three endocrinology or internal medicine clinics in an urban city of South Korea. Moderate‐intensity walking and PS counseling were recommended to both groups. The difference between the two groups was whether the intensity of the exercise was monitored by an ambulatory heart rate monitor (experimental group) or was self‐regulated (comparison group). Those programs were evaluated in relation to BMI, glycemic control (blood glucose level, glycosylated hemoglobin [HbA1c]), a vascular complication index (total cholesterol, high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, triglycerides, tissue plasminogen activator [t‐PA], plasminogen activator inhibitor‐1 [PAI‐1], Parma Cardiovascular Risk Index), and coping strategies at 3 and 6 months. Results: The experimental group members showed dramatic decreases in their glucose and HbA1c levels at 3 months. The values of t‐PA decreased significantly at baseline, compared to at 3 months. The levels of PAI‐1 continuously declined and the Parma Cardiovascular Risk Index score did not change significantly from baseline to at 3 months, but showed significant effects at 6 months. Conclusion: A combined program of intensified walking, using a heart rate monitor, with PS counseling is more helpful to prevent complications than self‐regulated exercise for persons with type 2 diabetes in Korea. 相似文献